annual current liabilities:
$37.11M+$20.33M(+121.14%)Summary
- As of today (June 29, 2025), LGND annual total current liabilities is $37.11 million, with the most recent change of +$20.33 million (+121.14%) on December 31, 2024.
- During the last 3 years, LGND annual current liabilities has fallen by -$4.55 million (-10.93%).
- LGND annual current liabilities is now -84.46% below its all-time high of $238.87 million, reached on December 31, 2017.
Performance
LGND Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$58.68M+$21.57M(+58.12%)Summary
- As of today (June 29, 2025), LGND quarterly total current liabilities is $58.68 million, with the most recent change of +$21.57 million (+58.12%) on March 31, 2025.
- Over the past year, LGND quarterly current liabilities has increased by +$40.87 million (+229.35%).
- LGND quarterly current liabilities is now -92.60% below its all-time high of $793.34 million, reached on September 30, 2018.
Performance
LGND quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
LGND Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +121.1% | +229.3% |
| 3 y3 years | -10.9% | +37.8% |
| 5 y5 years | +118.3% | +187.1% |
LGND Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.4% | +121.1% | -65.0% | +273.1% |
| 5 y | 5-year | -62.9% | +121.1% | -65.0% | +273.1% |
| alltime | all time | -84.5% | +358.2% | -92.6% | +1050.7% |
LGND Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $58.68M(+58.1%) |
| Dec 2024 | $37.11M(+121.1%) | $37.11M(+49.8%) |
| Sep 2024 | - | $24.77M(+33.4%) |
| Jun 2024 | - | $18.57M(+4.2%) |
| Mar 2024 | - | $17.82M(+6.2%) |
| Dec 2023 | $16.78M(-83.0%) | $16.78M(+6.7%) |
| Sep 2023 | - | $15.73M(-46.5%) |
| Jun 2023 | - | $29.39M(-70.3%) |
| Mar 2023 | - | $98.93M(+0.1%) |
| Dec 2022 | $98.81M(+137.2%) | $98.81M(-26.9%) |
| Sep 2022 | - | $135.24M(-19.4%) |
| Jun 2022 | - | $167.85M(+294.2%) |
| Mar 2022 | - | $42.58M(+2.2%) |
| Dec 2021 | $41.66M(-58.4%) | $41.66M(+14.8%) |
| Sep 2021 | - | $36.30M(-30.9%) |
| Jun 2021 | - | $52.50M(-45.2%) |
| Mar 2021 | - | $95.81M(-4.3%) |
| Dec 2020 | $100.11M(+488.8%) | $100.11M(+136.7%) |
| Sep 2020 | - | $42.30M(+44.5%) |
| Jun 2020 | - | $29.26M(+43.2%) |
| Mar 2020 | - | $20.44M(+20.2%) |
| Dec 2019 | $17.00M(-79.3%) | $17.00M(-52.4%) |
| Sep 2019 | - | $35.70M(-67.2%) |
| Jun 2019 | - | $108.98M(-41.6%) |
| Mar 2019 | - | $186.78M(+127.1%) |
| Dec 2018 | $82.25M(-65.6%) | $82.25M(-89.6%) |
| Sep 2018 | - | $793.34M(+25.4%) |
| Jun 2018 | - | $632.85M(+156.2%) |
| Mar 2018 | - | $246.98M(+3.4%) |
| Dec 2017 | $238.87M(+5.2%) | $238.87M(+3.1%) |
| Sep 2017 | - | $231.68M(+2.6%) |
| Jun 2017 | - | $225.84M(-0.5%) |
| Mar 2017 | - | $227.00M(-0.1%) |
| Dec 2016 | $227.13M(+1.9%) | $227.13M(+0.4%) |
| Sep 2016 | - | $226.13M(+2.6%) |
| Jun 2016 | - | $220.35M(+1700.2%) |
| Mar 2016 | - | $12.24M(-94.5%) |
| Dec 2015 | $222.82M(+878.2%) | $222.82M(+1271.0%) |
| Sep 2015 | - | $16.25M(-9.4%) |
| Jun 2015 | - | $17.95M(-1.1%) |
| Mar 2015 | - | $18.16M(-20.3%) |
| Dec 2014 | $22.78M(-21.3%) | $22.78M(+23.6%) |
| Sep 2014 | - | $18.43M(-1.0%) |
| Jun 2014 | - | $18.62M(-11.3%) |
| Mar 2014 | - | $21.00M(-27.4%) |
| Dec 2013 | $28.94M(-18.3%) | $28.94M(-10.8%) |
| Sep 2013 | - | $32.46M(-0.3%) |
| Jun 2013 | - | $32.57M(-1.4%) |
| Mar 2013 | - | $33.02M(-6.8%) |
| Dec 2012 | $35.44M(-18.8%) | $35.44M(+18.6%) |
| Sep 2012 | - | $29.88M(-1.8%) |
| Jun 2012 | - | $30.42M(+11.8%) |
| Mar 2012 | - | $27.21M(-37.7%) |
| Dec 2011 | $43.64M(+30.3%) | $43.64M(+2.8%) |
| Sep 2011 | - | $42.45M(+0.3%) |
| Jun 2011 | - | $42.31M(-5.1%) |
| Mar 2011 | - | $44.57M(+33.1%) |
| Dec 2010 | $33.49M(-35.8%) | $33.49M(-8.7%) |
| Sep 2010 | - | $36.68M(-15.9%) |
| Jun 2010 | - | $43.60M(+5.2%) |
| Mar 2010 | - | $41.43M(-20.6%) |
| Dec 2009 | $52.17M | $52.17M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $53.05M(+10.1%) |
| Jun 2009 | - | $48.20M(-8.9%) |
| Mar 2009 | - | $52.88M(-25.1%) |
| Dec 2008 | $70.61M(+38.5%) | $70.61M(+36.6%) |
| Sep 2008 | - | $51.70M(+15.9%) |
| Jun 2008 | - | $44.61M(+0.7%) |
| Mar 2008 | - | $44.31M(-13.1%) |
| Dec 2007 | $50.97M(-70.2%) | $50.97M(-14.8%) |
| Sep 2007 | - | $59.83M(-12.1%) |
| Jun 2007 | - | $68.06M(-80.0%) |
| Mar 2007 | - | $340.50M(+99.3%) |
| Dec 2006 | $170.81M(-27.4%) | $170.81M(-24.6%) |
| Sep 2006 | - | $226.41M(-15.6%) |
| Jun 2006 | - | $268.41M(+4.8%) |
| Mar 2006 | - | $256.03M(+8.9%) |
| Dec 2005 | $235.21M(+8.5%) | $235.21M(+4.7%) |
| Sep 2005 | - | $224.59M(+5.2%) |
| Jun 2005 | - | $213.48M(-1.3%) |
| Mar 2005 | - | $216.22M(-0.2%) |
| Dec 2004 | $216.71M(+35.7%) | $216.71M(+203.0%) |
| Sep 2004 | - | $71.53M(+16.4%) |
| Jun 2004 | - | $61.47M(+7.4%) |
| Mar 2004 | - | $57.26M(-64.1%) |
| Dec 2003 | $159.71M(+351.7%) | $159.71M(+245.0%) |
| Sep 2003 | - | $46.29M(+31.7%) |
| Jun 2003 | - | $35.15M(-7.1%) |
| Mar 2003 | - | $37.82M(+7.0%) |
| Dec 2002 | $35.35M(+11.4%) | $35.35M(+28.1%) |
| Sep 2002 | - | $27.61M(-12.8%) |
| Jun 2002 | - | $31.68M(-59.5%) |
| Mar 2002 | - | $78.31M(+146.8%) |
| Dec 2001 | $31.73M(+11.7%) | $31.73M(+26.7%) |
| Sep 2001 | - | $25.03M(-1.7%) |
| Jun 2001 | - | $25.45M(+11.4%) |
| Mar 2001 | - | $22.85M(-19.6%) |
| Dec 2000 | $28.41M(+37.3%) | $28.41M(+26.5%) |
| Sep 2000 | - | $22.45M(-7.9%) |
| Jun 2000 | - | $24.38M(+8.9%) |
| Mar 2000 | - | $22.39M(+8.2%) |
| Dec 1999 | $20.70M(-23.0%) | $20.70M(+7.8%) |
| Sep 1999 | - | $19.20M(-7.7%) |
| Jun 1999 | - | $20.80M(+4.0%) |
| Mar 1999 | - | $20.00M(-25.7%) |
| Dec 1998 | $26.90M(+24.0%) | $26.90M(+43.9%) |
| Sep 1998 | - | $18.70M(-5.1%) |
| Jun 1998 | - | $19.70M(+35.9%) |
| Mar 1998 | - | $14.50M(-33.2%) |
| Dec 1997 | $21.70M(+57.2%) | $21.70M(+77.9%) |
| Sep 1997 | - | $12.20M(-6.9%) |
| Jun 1997 | - | $13.10M(+0.8%) |
| Mar 1997 | - | $13.00M(-5.8%) |
| Dec 1996 | $13.80M(-12.1%) | $13.80M(+24.3%) |
| Sep 1996 | - | $11.10M(-11.9%) |
| Jun 1996 | - | $12.60M(-1.6%) |
| Mar 1996 | - | $12.80M(-18.5%) |
| Dec 1995 | $15.70M(+93.8%) | $15.70M(+44.0%) |
| Sep 1995 | - | $10.90M(+53.5%) |
| Mar 1995 | - | $7.10M(-12.3%) |
| Dec 1994 | $8.10M | $8.10M(+14.1%) |
| Sep 1994 | - | $7.10M(+39.2%) |
| Jun 1994 | - | $5.10M(0.0%) |
| Mar 1994 | - | $5.10M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total current liabilities?
- What is the all time high annual current liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual current liabilities year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly current liabilities year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total current liabilities?
The current annual current liabilities of LGND is $37.11M
What is the all time high annual current liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total current liabilities is $238.87M
What is Ligand Pharmaceuticals Incorporated annual current liabilities year-on-year change?
Over the past year, LGND annual total current liabilities has changed by +$20.33M (+121.14%)
What is Ligand Pharmaceuticals Incorporated quarterly total current liabilities?
The current quarterly current liabilities of LGND is $58.68M
What is the all time high quarterly current liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total current liabilities is $793.34M
What is Ligand Pharmaceuticals Incorporated quarterly current liabilities year-on-year change?
Over the past year, LGND quarterly total current liabilities has changed by +$40.87M (+229.35%)